Safety Study of DX243 for Hearing Loss in Noise
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study tests a new medicine (DX243) to see if it is safe and well-tolerated in people with hearing difficulties, especially trouble hearing speech in noisy environments. The goal is to understand how the body processes this medicine and whether it might help improve hearing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have noticed difficulty hearing in noisy environments for at least 6 months before screening
- You have a speech-in-noise hearing deficit (trouble understanding speech in background noise) in at least one ear, confirmed by hearing tests
- Your hearing ranges from normal to moderately severe impairment on audiometric testing
- You do not have a perforated eardrum (hole in the eardrum) or current ear infection
- You have not had any ear surgery in the past
- You are not taking any medications known to damage hearing (ototoxic drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, TJ0113, taken by mouth, to see if it can safely improve hearing in people with age-related hearing loss. It focuses on adults aged 65 to 80 with moderate to severe hearing loss in both ears.
This trial looks at how using platforms that change sound, like online meeting tools, might affect your hearing. It compares people who use these tools a lot with those who use them less.
This trial tests whether a combination of an antihistamine (clemastine fumarate) and specially designed sounds can improve how the brain processes hearing in middle-aged adults with mild hearing loss. It might help if you have trouble understanding speech in noisy settings.
This study tests an investigational drug called TRTL-913 in healthy volunteers first, then in adults with constant ringing in the ears (tinnitus). The goal is to see if it is safe and if it reduces tinnitus symptoms.
This study tests a drug given through the eardrum to help people with constant tinnitus (ringing in the ears) who have normal hearing but trouble understanding speech in noise. The goal is to see if it can improve hearing and reduce the ringing.
This study tests a new way to help people with age-related hearing loss understand conversations in noisy environments. It might improve your ability to hear clearly when there is background noise.
Hear when a new Age-related Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.